May 5, 2022 01:56 PM EDTUpdated 02:56 PM

Are pharma marketers finally moving away from traditional TV advertising? Yes, but it’s a slow roll

Beth Snyder Bulik

Senior Editor

Pharma marketers are finally starting to diversify the advertising media mix, a new study finds, but don’t count on any abrupt shifts away from tried …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Are pharma marketers finally moving away from traditional TV advertising? Yes, but it’s a slow roll

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

Novartis highlights overall M&A track record following MorphoSys impairment

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

Are phar­ma mar­keters fi­nal­ly mov­ing away from tra­di­tion­al TV ad­ver­tis­ing? Yes, but it’s a slow roll

Senior Editor

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

Are pharma marketers finally moving away from traditional TV advertising? Yes, but it’s a slow roll